EP 3466447 A1 20190410 - TOPICAL PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE FORMS OF SKIN WOUNDS AND MANUFACTURING METHOD THEREOF
Title (en)
TOPICAL PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE FORMS OF SKIN WOUNDS AND MANUFACTURING METHOD THEREOF
Title (de)
TOPISCHE PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON MEHREREN FORMEN VON HAUTWUNDEN UND HERSTELLUNGSVERFAHREN DAFÜR
Title (fr)
COMPOSITION PHARMACEUTIQUE À USAGE EXTERNE INDIQUÉE POUR LE TRAITEMENT D'ULCÈRES CUTANÉES MULTIPLES
Publication
Application
Priority
- CN 201610369784 A 20160530
- CN 2017085443 W 20170523
Abstract (en)
The invention generally relates to a liquid topical pharmaceutical composition used in treating various skin wounds. The composition is characterized by strong moisture absorption and retention capabilities and being able to quickly seal the wound. The composition can resist oxidation, effectively inhibit bacteria and sterilization, protect germinal cells from further damage, eliminate wound swelling and promote wound healing. The pharmaceutical composition can be widely used in the treatment of burn, skin abrasion, laceration, infectious skin ulcer and wound exposure, save dressing and be used in a convenient and highly effective way.
IPC 8 full level
A61K 31/165 (2006.01); A61K 31/7036 (2006.01); A61K 36/744 (2006.01); A61K 36/756 (2006.01); A61K 36/87 (2006.01); A61K 36/898 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01); A61P 17/02 (2006.01)
CPC (source: CN EP US)
A61K 9/0014 (2013.01 - CN EP); A61K 31/047 (2013.01 - CN EP); A61K 31/10 (2013.01 - EP); A61K 31/165 (2013.01 - CN EP US); A61K 31/55 (2013.01 - EP); A61K 31/7036 (2013.01 - CN EP US); A61K 36/185 (2013.01 - CN); A61K 36/232 (2013.01 - CN US); A61K 36/324 (2013.01 - CN US); A61K 36/328 (2013.01 - CN US); A61K 36/48 (2013.01 - CN); A61K 36/481 (2013.01 - CN US); A61K 36/484 (2013.01 - CN US); A61K 36/537 (2013.01 - CN US); A61K 36/539 (2013.01 - CN US); A61K 36/65 (2013.01 - CN US); A61K 36/71 (2013.01 - CN US); A61K 36/718 (2013.01 - CN); A61K 36/744 (2013.01 - CN EP US); A61K 36/756 (2013.01 - CN EP US); A61K 36/87 (2013.01 - CN EP US); A61K 36/889 (2013.01 - CN US); A61K 36/896 (2013.01 - CN); A61K 36/898 (2013.01 - CN EP US); A61K 45/06 (2013.01 - US); A61K 47/10 (2013.01 - CN US); A61K 47/20 (2013.01 - CN US); A61K 47/22 (2013.01 - CN US); A61P 7/10 (2017.12 - CN); A61P 17/02 (2017.12 - CN EP US); A61P 29/00 (2017.12 - CN); A61P 31/02 (2017.12 - CN); A61P 31/04 (2017.12 - CN); A61K 47/10 (2013.01 - EP); A61K 47/20 (2013.01 - EP); A61K 47/22 (2013.01 - EP); A61K 2236/33 (2013.01 - CN US); A61K 2236/331 (2013.01 - CN)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3466447 A1 20190410; EP 3466447 A4 20200318; CN 105833279 A 20160810; CN 105833279 B 20210622; CN 113413375 A 20210921; JP 2019517533 A 20190624; JP 6681482 B2 20200415; US 10864240 B2 20201215; US 11571452 B2 20230207; US 2019125815 A1 20190502; US 2021106638 A1 20210415; WO 2017206758 A1 20171207
DOCDB simple family (application)
EP 17805703 A 20170523; CN 201610369784 A 20160530; CN 2017085443 W 20170523; CN 202110817611 A 20160530; JP 2018563615 A 20170523; US 201816204352 A 20181129; US 202017102529 A 20201124